Why tech and life sciences lead the way
As the US venture debt market expands, the bulk of opportunities rely on the VC market and have stood the test of time, says Hercules Capital’s Scott Bluestein.
1 September 2019•5 mins read
As the US venture debt market expands, the bulk of opportunities rely on the VC market and have stood the test of time, says Hercules Capital’s Scott Bluestein.
InterVest capital partners on data and discipline to ABF investing
1 October 2026 · 5 mins read
Main Street Capital on a structurally different asset class for LPs
1 October 2026 · 7 mins read
Apogem Capital on why a credit-first approach matters
1 September 2026 · 6 mins read
RBC BlueBay Asset Management on challenged arbitrage and barbells in CLOs
1 September 2026 · 5 mins read
Partners Group on loss avoidance front of mind as refinancings dominate
1 September 2026 · 8 mins read
Gordon Brothers: Navigating hidden risks in private credit
1 September 2026 · 5 mins read
Kartesia: Where discipline and positioning still earn a premium
1 September 2026 · 6 mins read
